Guillain-Barré syndrome
Conditions
Interventions
GBS group:none
Sponsors
First hospital of shanxi medical university
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Provide signed and dated informed consent; 2. Male or female, age >= 18 years; 3. Meet the diagnostic criteria for GBS; 4. Drug treatment started within 14 days of onset (calculated as limb weakness).
Exclusion criteria
Exclusion criteria: 1. Previous use of egamod, IVIg, plasmapheresis, rituximab, immunosuppressants (e.g., azathioprine, cyclosporine, mycophenolate mofetil, tacrolimus, prednisone, etc.) within 28 days prior to treatment with egarmod or IVIg; 2. Patients have evidence supporting the diagnosis of other peripheral neuropathy; 3. Have serious comorbidities affecting functional scores, such as malignant tumors, severe cardiovascular disease, severe chronic obstructive pulmonary disease, etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Guillain-Barré Syndrome Disability Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| INCAT Disability Scale;I-RODS Scale;Grip strength;MRC sum scores; | — |
Countries
China
Contacts
Public ContactWei zhang
First hospital of shanxi medical university
Outcome results
None listed